Satellite I: National Center for Functional Glycomics (NCFG)
Glycoscience Tools and Biological Functions 
Friday November 18, 2022
10:00am - 1:00pm EST
Virtual

Moderators- Drs. Rick Cummings and Jamie Heimburg-Molinaro


(tentative schedule as of 10/21/22) 

10AM-10:10AM
Welcome and Introductions
Richard D. Cummings, PhD, Beth Israel, Deaconess Medical Center and Director of the NCFG

10:10AM-10:30AM
"Anti-carbohydrate antibodies as biomarkers for type 1 diabetes progression”
Sharad Purohit, PhD, Augusta University

10:35AM-10:55AM
“Understanding factors that influence natural antibody production”
Connie Arthur, PhD, Brigham and Women’s Hospital 

11:00AM-11:20AM
"A glycan-based approach to cell characterization and isolation: Hematopoiesis as a paradigm"
Hannes Buelow, PhD, Albert Einstein College of Medicine 

11:25AM-11:35AM  Short break

11:35AM-11:55AM
“A PSGL-1 glycomimetic reduces thrombus burden without affecting hemostasis”
Diane Park, PhD, Beth Israel Deaconess Medical Center

12:00PM-12:20PM
“Uniquely human properties of Siglec-11 and Siglec-16”
Dillon Chen, PhD, University of California, San Diego

12:25PM-12:45PM
“Glycomimetic array platforms for investigating higher-order glycan-protein interactions”
Kamil Godula, PhD, University of California, San Diego

12:50PM-1:00PM
Closing Remarks and Discussion